首页 > 最新文献

Journal of Medical Evidence最新文献

英文 中文
Clinical depression amongst surgeons – Is it turning malignant? 外科医生的临床抑郁——是否会变成恶性?
Pub Date : 2023-01-01 DOI: 10.4103/jme.jme_137_22
Kaushik Bhattacharya, N. Bhattacharya
{"title":"Clinical depression amongst surgeons – Is it turning malignant?","authors":"Kaushik Bhattacharya, N. Bhattacharya","doi":"10.4103/jme.jme_137_22","DOIUrl":"https://doi.org/10.4103/jme.jme_137_22","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133852411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene therapy and its applications 基因治疗及其应用
Pub Date : 2023-01-01 DOI: 10.4103/jme.jme_65_21
A. Bansal, R. Prakash, Swati Agarwal, U. Advani
Gene therapy is the treatment of abnormal or mutated genes present in cells through the addition of healthy genes or replacement/deletion/site-specific modification of faulty genes. Deoxyribonucleic acid, messenger ribonucleic acid (RNA), small interference RNA, microsomal RNA and antisense oligonucleotides are the genetic materials implicated in gene therapy. They are inserted into the diseased cells using viral or non-viral vectors through an in vivo or ex vivo transduction. Gamma retrovirus, lentivirus, herpesvirus, adenovirus and adeno-associated virus are common viral vectors, while transposons, cationic polymers, dendrimers and cell-penetrating peptides or liposomes are common non-viral vectors. Allologous or autologous T cells, haematopoietic stem cells and chimeric antigen receptor T cells are used for ex vivo gene transduction. Conventional gene therapy of inserting new genetic material shows toxicity such as off-target effects, altered immune responses, inflammatory reactions and possible oncogenic transformation in the recipient. Newer gene editing techniques such as zinc-finger nuclease, transcription activator-like effector nucleases and clustered regularly interspaced short palindromic repeats allow the site-specific correction or control of expression of mutated genes present in cells. Until August 2020, 23 gene-based medicines received approval from drug regulatory agencies in various countries and 362 were in development. Single-gene disorders have shown encouraging results, but evidence of using gene therapy in polygenic and common age-related diseases is still required. Recently, the horizon of gene therapy widened to include COVID vaccines and as an adjunct to chemotherapy. If we could overcome its limitations such as immunogenicity, mutagenicity and high costs, gene therapy can be the medicine of the next generation.
基因治疗是通过添加健康基因或替换/删除/位点特异性修饰缺陷基因来治疗细胞中存在的异常或突变基因。脱氧核糖核酸、信使核糖核酸(RNA)、小干扰RNA、微粒体RNA和反义寡核苷酸是参与基因治疗的遗传物质。它们通过体内或体外转导,利用病毒或非病毒载体插入病变细胞。逆转录病毒、慢病毒、疱疹病毒、腺病毒和腺相关病毒是常见的病毒载体,而转座子、阳离子聚合物、树突和细胞穿透肽或脂质体是常见的非病毒载体。异体或自体T细胞、造血干细胞和嵌合抗原受体T细胞用于体外基因转导。插入新遗传物质的传统基因治疗显示出毒性,如脱靶效应、免疫反应改变、炎症反应和可能的受体致癌转化。较新的基因编辑技术,如锌指核酸酶、转录激活物样效应核酸酶和聚集规律间隔的短回传重复序列,允许对细胞中存在的突变基因的表达进行位点特异性校正或控制。截至2020年8月,23种基于基因的药物获得了各国药物监管机构的批准,362种药物正在开发中。单基因疾病已经显示出令人鼓舞的结果,但在多基因和常见的与年龄有关的疾病中使用基因治疗的证据仍然需要。最近,基因治疗的范围扩大到包括COVID疫苗和作为化疗的辅助手段。如果我们能克服其免疫原性、诱变性和高成本等局限性,基因治疗可能成为下一代的药物。
{"title":"Gene therapy and its applications","authors":"A. Bansal, R. Prakash, Swati Agarwal, U. Advani","doi":"10.4103/jme.jme_65_21","DOIUrl":"https://doi.org/10.4103/jme.jme_65_21","url":null,"abstract":"Gene therapy is the treatment of abnormal or mutated genes present in cells through the addition of healthy genes or replacement/deletion/site-specific modification of faulty genes. Deoxyribonucleic acid, messenger ribonucleic acid (RNA), small interference RNA, microsomal RNA and antisense oligonucleotides are the genetic materials implicated in gene therapy. They are inserted into the diseased cells using viral or non-viral vectors through an in vivo or ex vivo transduction. Gamma retrovirus, lentivirus, herpesvirus, adenovirus and adeno-associated virus are common viral vectors, while transposons, cationic polymers, dendrimers and cell-penetrating peptides or liposomes are common non-viral vectors. Allologous or autologous T cells, haematopoietic stem cells and chimeric antigen receptor T cells are used for ex vivo gene transduction. Conventional gene therapy of inserting new genetic material shows toxicity such as off-target effects, altered immune responses, inflammatory reactions and possible oncogenic transformation in the recipient. Newer gene editing techniques such as zinc-finger nuclease, transcription activator-like effector nucleases and clustered regularly interspaced short palindromic repeats allow the site-specific correction or control of expression of mutated genes present in cells. Until August 2020, 23 gene-based medicines received approval from drug regulatory agencies in various countries and 362 were in development. Single-gene disorders have shown encouraging results, but evidence of using gene therapy in polygenic and common age-related diseases is still required. Recently, the horizon of gene therapy widened to include COVID vaccines and as an adjunct to chemotherapy. If we could overcome its limitations such as immunogenicity, mutagenicity and high costs, gene therapy can be the medicine of the next generation.","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131600438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gender inequality during the COVID-19 pandemic in India 2019冠状病毒病大流行期间印度的性别不平等
Pub Date : 2023-01-01 DOI: 10.4103/jme.jme_100_22
Boppana Sujwal, Kumbha Gopi, B. Sahoo, Debkumar Pal, M. Taywade
{"title":"Gender inequality during the COVID-19 pandemic in India","authors":"Boppana Sujwal, Kumbha Gopi, B. Sahoo, Debkumar Pal, M. Taywade","doi":"10.4103/jme.jme_100_22","DOIUrl":"https://doi.org/10.4103/jme.jme_100_22","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127980000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obituary of Dr. Tehemton E. Udwadia Tehemton E. Udwadia博士的讣告
Pub Date : 2023-01-01 DOI: 10.4103/jme.jme_27_23
P. Bhatia
{"title":"Obituary of Dr. Tehemton E. Udwadia","authors":"P. Bhatia","doi":"10.4103/jme.jme_27_23","DOIUrl":"https://doi.org/10.4103/jme.jme_27_23","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124879232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pros and cons of studying MBBS abroad 出国学习MBBS的利弊
Pub Date : 2023-01-01 DOI: 10.4103/jme.jme_140_22
Abhishek Kumar, Pragya Pandey
{"title":"The pros and cons of studying MBBS abroad","authors":"Abhishek Kumar, Pragya Pandey","doi":"10.4103/jme.jme_140_22","DOIUrl":"https://doi.org/10.4103/jme.jme_140_22","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122659401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Langerhans cell histiocytosis in a newborn 新生儿朗格汉斯细胞组织细胞增多症
Pub Date : 2022-09-01 DOI: 10.4103/jme.jme_139_22
Mudit Arora, A. Soni, S. Saluja, M. Modi
{"title":"Langerhans cell histiocytosis in a newborn","authors":"Mudit Arora, A. Soni, S. Saluja, M. Modi","doi":"10.4103/jme.jme_139_22","DOIUrl":"https://doi.org/10.4103/jme.jme_139_22","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121922634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous inferior vena caval filter placement 经皮下腔静脉过滤器放置
Pub Date : 2022-09-01 DOI: 10.4103/jme.jme_192_20
S. Madaan, U. Chauhan, Pankaj Sharma
{"title":"Percutaneous inferior vena caval filter placement","authors":"S. Madaan, U. Chauhan, Pankaj Sharma","doi":"10.4103/jme.jme_192_20","DOIUrl":"https://doi.org/10.4103/jme.jme_192_20","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128645623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telemedicine: A case of turning adversity into opportunity 远程医疗:化逆境为机遇的案例
Pub Date : 2022-09-01 DOI: 10.4103/jme.jme_143_22
Meenu Singh, K. Kumar
{"title":"Telemedicine: A case of turning adversity into opportunity","authors":"Meenu Singh, K. Kumar","doi":"10.4103/jme.jme_143_22","DOIUrl":"https://doi.org/10.4103/jme.jme_143_22","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"16 12","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120822570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defeating the deficits: Mask banks offer a promising solution 战胜赤字:面具银行提供了一个有希望的解决方案
Pub Date : 2022-09-01 DOI: 10.4103/jme.jme_200_20
S Kumar, Tejal Mehta, Prateek Jain, Anushka Garg, Shriharmender Kant, Ranjeeta Kumari, A. Bhadoria
{"title":"Defeating the deficits: Mask banks offer a promising solution","authors":"S Kumar, Tejal Mehta, Prateek Jain, Anushka Garg, Shriharmender Kant, Ranjeeta Kumari, A. Bhadoria","doi":"10.4103/jme.jme_200_20","DOIUrl":"https://doi.org/10.4103/jme.jme_200_20","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131272206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The timing of a major operative intervention after a positive COVID-19 test affects post-operative mortality COVID-19检测呈阳性后进行重大手术干预的时机会影响术后死亡率
Pub Date : 2022-09-01 DOI: 10.4103/jme.jme_134_22
Chander Mohan, S. Nundy
{"title":"The timing of a major operative intervention after a positive COVID-19 test affects post-operative mortality","authors":"Chander Mohan, S. Nundy","doi":"10.4103/jme.jme_134_22","DOIUrl":"https://doi.org/10.4103/jme.jme_134_22","url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114781694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical Evidence
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1